Cullinan Associates’s Zoetis ZTS Stock Holding History

Cullinan Associates’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,500	Closed	-$296K	–	213
2026 Q1	$296K	Hold	2,500	–	–	0.02%	185
2025 Q4	$315K	Hold	2,500	–	–	0.02%	183
2025 Q3	$366K	Hold	2,500	–	–	0.02%	181
2025 Q2	$390K	Hold	2,500	–	–	0.03%	183
2025 Q1	$412K	Sell	2,500 -2,400	-49%	-$399K	0.03%	174
2024 Q4	$798K	Hold	4,900	–	–	0.05%	142
2024 Q3	$930K	Hold	4,900	–	–	0.05%	147
2024 Q2	$849K	Sell	4,900 -500	-9%	-$83.2K	0.05%	153
2024 Q1	$914K	Hold	5,400	–	–	0.05%	156
2023 Q4	$1.07M	Hold	5,400	–	–	0.06%	141
2023 Q3	$939K	Hold	5,400	–	–	0.05%	146
2023 Q2	$930K	Hold	5,400	–	–	0.05%	162
2023 Q1	$899K	Buy	5,400 +1,744	+48%	+$286K	0.05%	161
2022 Q4	$536K	Buy	3,656 +656	+22%	+$97.1K	0.03%	199
2022 Q3	$445K	Hold	3,000	–	–	0.03%	183
2022 Q2	$516K	Buy	3,000 +1,250	+71%	+$216K	0.03%	176
2022 Q1	$330K	Hold	1,750	–	–	0.02%	203
2021 Q4	$427K	Buy	+1,750	New	+$383K	0.02%	189

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cullinan Associates's ZTS Position: Q2 2026 in Review

Cullinan Associates sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,500 shares — an estimated $296K sold.

Cullinan Associates first reported a position in ZTS in Q4 2021 and held it in 18 quarters. The position peaked at $1.07M in Q4 2023. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

Cullinan Associates reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
Cullinan Associates sold 2,500 Zoetis shares in Q2 2026, an estimated $296K.
Cullinan Associates first reported a position in Zoetis in Q4 2021 and held it in 18 quarters.
Cullinan Associates's Zoetis position peaked at $1.07M in Q4 2023.
1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.